Cyclic tripeptide mimetics as plasmin inhibitors
US9133194B2 · kind B2 · utility
0Cited by
0References
18Claims
0Family size
Inventors
Key dates
| Filing date | Jul 9, 2012 |
| Grant date | Sep 15, 2015 |
| Priority date | — |
| Expiry date | Jul 9, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to peptide mimetics comprising the residues P4-P3-P2-P1, which were cyclized between the side chains of P3 and P2 amino acid and are, as inhibitors of the serine protease plasmin, suitable to be used to inhibit fibrinolysis and thus to reduce blood loss in hyperfibrinolytic conditions, for example during surgery.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.